CanaQuest Medical Corp. has won the Go Global Awards “Business of the Year – Category of Life Science”, presented by the International Trade Council.
The final judging took place during the Think Global Conference on October 22nd and 23rd in Chicago. This recognition will further open doors for international business opportunities. CanaQuest presented before a select judging panel and an audience of CEOs, investors and Government Ministers and Ambassadors. To view the presentation provided, visit http://nnw.fm/Go-Global-Awards-Presentation.
Recently, CanaQuest was granted a cannabis sales-import-export license from Health Canada. Additionally, CanaQuest filed an international patent on its first game-changing formulation, MentabinolTM, which protects THC users from negative psychotic side effects.
The Company is focused on the development of proprietary research and products utilizing cannabis oil combined with other botanical extracts, including algae oil. Positive data from CanaQuest’s research and pre- clinical trials has positioned the Company to bring its first CBD and THC based products to market.
CanaQuest has engaged two prestigious Canadian universities, Western University and the University of Waterloo, to provide research and to create these unique formulations and products. Our research is focused on mitigation of the spread of cancerous tumors and the development of novel pharmacotherapies for mental health.
The company has found a competitive advantage working with Dr. Steve Laviolette, a scientific veteran with over 13 years of research experience in the field of mental health and cannabis, and his dedicated scientific team of 12 scientists at Western University. This partnership gives our Company a tremendous competitive advantage compared to sporadic publicly disclosed research in this area. The completed pre-clinical trials at the Western University lab have demonstrated exciting results.
“We continue to be enthusiastic about our partnership with CanaQuest, and we are proud they are winners of the Go Global Awards “Business of the Year – Category of Life Science,” said Dr. Steven Laviolette. “The results of our research have demonstrated safer and clinically superior cannabinoid formulations aimed at treating the symptoms of various mental disorders.”
Paul Ramsay, Co-Founder and President of CanaQuest, added, “Being a winner of the Go Global Awards Business of the Year – category of Life Science, out of over 3,000 applications, is an honor and speaks highly of the tremendous accomplishments by Dr. Steven Laviolette and his team.”